7-Amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, 98%, 100mg

2-(4-Amino-1H-pyrazol-1-yl)ethanol, 95.0%, 250mg

1-Chloro-4-(isopropylsulfonyl)-2-nitrobenzene, 95.0%, 1g

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 100g

3-(3-methylphenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

pBR328-Marker ready-to-use, 500 µl, 1 x 0,5 ml

5-Methylthiophene-3-boronic acid, 95+%, 25g

2-Bromo-2-(2-chlorophenyl)acetic acid, 95.0%, 500g

2-{[(9h-fluoren-9-ylmethoxy)carbonyl](propan-2-yl)amino}acetic acid, 95%, 500mg

5-Fluoro-2-hydrazinylpyridine dihydrochloride, 95.0%, 10g

1-Propyl-1H-indole-2,3-dione, 5g

3-Cyanobenzohydrazide, 95.0%, 250mg

N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95+%, 5g